AgingResearch.NewsJoin free

ACADIA Pharmaceuticals

CompanyUnited StatesFounded 1993

Wikidata

ACADIA Pharmaceuticals develops one asset, in phase 2 (ACP-204 in Alzheimer's disease psychosis). Mostly small molecule acting on HTR2A; based in the United States, founded in 1993.

1
Asset
Furthest stage
Phase 2
1
Trial
0
Signals

Pipeline

1

  • ACP-204

    Serotonin 5-HT2A receptor inverse agonist / antagonist

    Phase 2, Small molecule, HTR2A, Alzheimer's disease psychosis

Full company profiles: pipeline, trials, funding and people.

See Pro

In the full profile

  • Evidence behind the mechanisms1
  • Trials1
  • Similar companies4

Intelligence